These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 3174903)

  • 21. Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients.
    Kirkpatrick B; Carpenter WT; Maeda K; Buchanan RW; Breier A; Tamminga CA
    Biol Psychiatry; 1992 Dec; 32(11):1049-54. PubMed ID: 1467385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
    Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
    Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma prolactin concentrations and psychopathology in chronic schizophrenia.
    Kleinman JE; Weinberger DR; Rogol AD; Bigelow LB; Klein ST; Gillin JC; Wyatt RJ
    Arch Gen Psychiatry; 1982 Jun; 39(6):655-7. PubMed ID: 6979991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia.
    Albayrak Y; Beyazyüz M; Beyazyüz E; Kuloğlu M
    Nord J Psychiatry; 2014 Jul; 68(5):341-6. PubMed ID: 24094029
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolactin shifts after neuroleptic withdrawal.
    Green AI; Faraone SV; Brown WA
    Psychiatry Res; 1990 Jun; 32(3):213-9. PubMed ID: 1975101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems.
    Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R
    Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal instability of hormone responses in schizophrenia.
    Cleghorn JM; Brown GM; Brown PJ; Kaplan RD; Mitton J
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):545-9. PubMed ID: 6686692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist.
    Naber D; Münch U; Wissmann J; Grosse R; Ritt R; Welter D
    Acta Psychiatr Scand; 1983 Apr; 67(4):265-71. PubMed ID: 6305111
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients.
    Csernansky JG; Kaplan J; Holman CA; Hollister LE
    Psychopharmacology (Berl); 1983; 81(2):115-8. PubMed ID: 6138793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostaglandin E1 treatment of schizophrenia.
    Kaiya H
    Biol Psychiatry; 1984 Mar; 19(3):457-63. PubMed ID: 6539131
    [No Abstract]   [Full Text] [Related]  

  • 31. m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.
    Krystal JH; Seibyl JP; Price LH; Woods SW; Heninger GR; Aghajanian GK; Charney DS
    Arch Gen Psychiatry; 1993 Aug; 50(8):624-35. PubMed ID: 8102048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Propranolol in schizophrenia. Clinical, metabolic, and pharmacological findings.
    Hanssen T; Heyden T; Sundberg I; Alfredsson G; Nybäck H; Wetterberg L
    Arch Gen Psychiatry; 1980 Jun; 37(6):685-90. PubMed ID: 7387339
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin response to sodium valproate in schizophrenics with and without tardive dyskinesia.
    Monteleone P; Maj M; Ariano MG; Iovino M; Fiorenza L; Steardo L
    Psychopharmacology (Berl); 1988; 96(2):223-6. PubMed ID: 3148149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anterior pituitary hormone secretion in chronic schizophrenia--an approach to neurohumoral mechanisms.
    Johnstone EC; Crow TJ; Mashiter K
    Psychol Med; 1977 May; 7(2):223-8. PubMed ID: 877185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroendocrine evidence that clozapine's serotonergic antagonism is relevant to its efficacy in treating hallucinations and other positive schizophrenic symptoms.
    Jones H; Curtis VA; Wright P; Lucey JV
    Am J Psychiatry; 1998 Jun; 155(6):838-40. PubMed ID: 9619161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Seasonal variation of serum high density lipoprotein cholesterol levels in men.
    Sasaki J; Kumagae G; Sata T; Ikeda M; Tsutsumi S; Arakawa K
    Atherosclerosis; 1983 Aug; 48(2):167-72. PubMed ID: 6615581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prolactin stimulating effects of amoxapine and loxapine in psychiatric patients.
    Robertson AG; Berry R; Meltzer HY
    Psychopharmacology (Berl); 1982; 78(3):287-92. PubMed ID: 6818584
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between testosterone, gonadotropins and prolactin and severity of negative symptoms in male patients with chronic schizophrenia.
    Akhondzadeh S; Rezaei F; Larijani B; Nejatisafa AA; Kashani L; Abbasi SH
    Schizophr Res; 2006 Jun; 84(2-3):405-10. PubMed ID: 16545544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolactin, subjective well-being and sexual dysfunction: an open label observational study comparing quetiapine with risperidone.
    Westheide J; Cvetanovska G; Albrecht C; Bliesener N; Cooper-Mahkorn D; Creutz C; Hornung WP; Klingmüller D; Lemke MR; Maier W; Schubert M; Sträter B; Kühn KU
    J Sex Med; 2008 Dec; 5(12):2816-26. PubMed ID: 18466271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circadian and sleep-related endocrine rhythms in schizophrenia.
    Van Cauter E; Linkowski P; Kerkhofs M; Hubain P; L'Hermite-Balériaux M; Leclercq R; Brasseur M; Copinschi G; Mendlewicz J
    Arch Gen Psychiatry; 1991 Apr; 48(4):348-56. PubMed ID: 1848971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.